JPRN-UMIN000018311
Completed
未知
The effect of trelagliptin on vascular endothelial functions in patients with type II diabetes mellitus. - The effect of trelagliptin on vascular endothelial functions in patients with type II diabetes mellitus.
Ise Red Cross Hospital Department of Metabolic Diseases0 sites30 target enrollmentJuly 15, 2015
ConditionsPatients with type 2 diabetes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients with type 2 diabetes
- Sponsor
- Ise Red Cross Hospital Department of Metabolic Diseases
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) type 1 diabetes 2\) secondary diabetes 3\) Patients receiving insulin or GLP\-1 analogue therapy 4\) Poor\-controlled diabetes (HbA1c\>10\.0 % or fasting blood glucose levels greater than 250mg/dl) 5\) History of stroke, acute coronary syndrome or any cardiovascular diseases needed for inpatient\-treatments within 6 months 6\) Either level of aspartate aminotransaminase or alanine aminotransferase exceed three\-fold of the normal limits 7\) renal insufficiency: serum creatinine\>1\.5 8\) Malignancies or other diseases with poor prognosis 9\) Pregnant 10\) Subjects whose doctor in charge do not agree to join the trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The effects of Teneligliptin on endothelial function in type 2 diabetes mellitus with chronic kidney diseaseType 2 diabetes mellitus with chronic kidney diseaseJPRN-UMIN000017180Dokkyo Medical University50
Completed
Not Applicable
Effect of teneligliptin on endothelial dysfunction induced by postprandial hypelipidemiaMetabolic syndromeJPRN-UMIN000012588Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences20
Recruiting
Not Applicable
Effects of vildagliptin on vascular endothelial function and lipid profile in patients with type 2 diabetes mellitusJPRN-UMIN000008134Department of Medicine and Bioregulatory Sciences, The University of Tokuhsima, Graduate School of Health Biosciences20
Completed
Phase 3
The effect of vildagliptin on endothelium-dependent vasodilatation. A double blind, cross-over study in type 2 diabetes mellitus.endothelial functionEndothelium-dependent vasodilatation1001265310003216NL-OMON32871niversitair Medisch Centrum Sint Radboud16
Active, not recruiting
Phase 1
The effect of vildagliptin on endothelium-dependent vasodilatation. A double blind, cross-over study in type 2 diabetes. - Vildagliptin and vasodilatatioThe effect of vildagliptin on endothelial dysfunction in type 2 diabetes, assessed by measuring endothelium-dependent vasodilatationMedDRA version: 12.0Level: LLTClassification code 10048554Term: Endothelial dysfunctionEUCTR2009-016053-18-NLMC St Radboud16